Azithromycin/hydroxychloroquine/tocilizumabQTc prolongation and off label use: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1828卷 / 1期

关键词：

D O I：

10.1007/s40278-020-85181-9

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：105 / 105

相关论文

共 50 条

[1] Azithromycin/hydroxychloroquine interactionQT interval prolongation following off-label use: case report
[J]. Reactions Weekly, 2020, 1818 (1) : 54 - 54
[2] Azithromycin/hydroxychloroquineQT prolongation following off label use: case report
[J]. Reactions Weekly, 2022, 1896 (1) : 80 - 80
[3] Azithromycin/hydroxychloroquine/oseltamivirPsychotic agitation following off label use: case report
[J]. Reactions Weekly, 2022, 1911 (1) : 93 - 93
[4] Azithromycin/hydroxychloroquine/oseltamivirUrticarial reactions following off label use: case report
[J]. Reactions Weekly, 2020, 1823 (1) : 92 - 92
[5] Azithromycin/hydroxychloroquineQT prolongation and ventricular extrasystole secondary to off label use: case report
[J]. Reactions Weekly, 2021, 1836 (1) : 157 - 157
[6] Azithromycin/hydroxychloroquine/nitazoxanideDiarrhoea and lack of efficacy following off-label use: case report
[J]. Reactions Weekly, 2023, 1940 (1) : 104 - 104
[7] Azithromycin/hydroxychloroquineCorrected QT-interval prolongation following off label use: case report
[J]. Reactions Weekly, 2020, 1823 (1) : 91 - 91
[8] Azithromycin/hydroxychloroquine off label usePustular psoriasis following misuse: case report
[J]. Reactions Weekly, 2022, 1898 (1) : 105 - 105
[9] Azithromycin/hydroxychloroquineQTc prolongation during off-label treatment: case report
[J]. Reactions Weekly, 2021, 1845 (1) : 95 - 95
[10] Ceftriaxone/hydroxychloroquine/tocilizumabQT prolongation, torsade-de-pointes and off label use: case report
[J]. Reactions Weekly, 2020, 1833 (1) : 116 - 116

← 1 2 3 4 5 →